345 related articles for article (PubMed ID: 30120040)
1. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults.
Bowman GL; Dayon L; Kirkland R; Wojcik J; Peyratout G; Severin IC; Henry H; Oikonomidi A; Migliavacca E; Bacher M; Popp J
Alzheimers Dement; 2018 Dec; 14(12):1640-1650. PubMed ID: 30120040
[TBL] [Abstract][Full Text] [Related]
2. Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood-Brain Barrier Permeability in Older Adults.
Dayon L; Cominetti O; Wojcik J; Galindo AN; Oikonomidi A; Henry H; Migliavacca E; Kussmann M; Bowman GL; Popp J
J Proteome Res; 2019 Mar; 18(3):1162-1174. PubMed ID: 30702894
[TBL] [Abstract][Full Text] [Related]
3. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease.
Janelidze S; Mattsson N; Stomrud E; Lindberg O; Palmqvist S; Zetterberg H; Blennow K; Hansson O
Neurology; 2018 Aug; 91(9):e867-e877. PubMed ID: 30054439
[TBL] [Abstract][Full Text] [Related]
4. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
[TBL] [Abstract][Full Text] [Related]
5. Plasma and cerebrospinal fluid inflammation and the blood-brain barrier in older surgical patients: the Role of Inflammation after Surgery for Elders (RISE) study.
Vasunilashorn SM; Ngo LH; Dillon ST; Fong TG; Carlyle BC; Kivisäkk P; Trombetta BA; Vlassakov KV; Kunze LJ; Arnold SE; Xie Z; Inouye SK; Libermann TA; Marcantonio ER;
J Neuroinflammation; 2021 Apr; 18(1):103. PubMed ID: 33931093
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A
CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
Drake JD; Chambers AB; Ott BR; Daiello LA;
J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
[TBL] [Abstract][Full Text] [Related]
10. Protective Role of Cerebrospinal Fluid Inflammatory Cytokines in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease Carrying Apolipoprotein E4 Genotype.
Motta C; Finardi A; Toniolo S; Di Lorenzo F; Scaricamazza E; Loizzo S; Mercuri NB; Furlan R; Koch G; Martorana A
J Alzheimers Dis; 2020; 76(2):681-689. PubMed ID: 32538836
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD146, a cerebrospinal fluid marker for neuroinflammation, promotes blood-brain barrier dysfunction.
Wang D; Duan H; Feng J; Xiang J; Feng L; Liu D; Chen X; Jing L; Liu Z; Zhang D; Hao H; Yan X
Theranostics; 2020; 10(1):231-246. PubMed ID: 31903117
[TBL] [Abstract][Full Text] [Related]
12. Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
Oikonomidi A; Tautvydaitė D; Gholamrezaee MM; Henry H; Bacher M; Popp J
J Alzheimers Dis; 2017; 60(1):273-281. PubMed ID: 28826184
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.
Bowman GL; Kaye JA; Moore M; Waichunas D; Carlson NE; Quinn JF
Neurology; 2007 May; 68(21):1809-14. PubMed ID: 17515542
[TBL] [Abstract][Full Text] [Related]
14. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
[TBL] [Abstract][Full Text] [Related]
15. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?
Ye BS; Lee WW; Ham JH; Lee JJ; Lee PH; Sohn YH;
Eur J Neurol; 2016 May; 23(5):948-57. PubMed ID: 26917248
[TBL] [Abstract][Full Text] [Related]
16. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
18. Glial activation and inflammation along the Alzheimer's disease continuum.
Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease.
Bruno M; Bonomi CG; Ricci F; Di Donna MG; Mercuri NB; Koch G; Martorana A; Motta C
Eur J Neurol; 2024 Jan; 31(1):e16095. PubMed ID: 37823706
[TBL] [Abstract][Full Text] [Related]
20. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
